Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Appili Therapeutics submits CTA with Health Canada to sponsor trial of favipiravir as preventative measure against Covid-19
Appili Therapeutics submits CTA with Health Canada to sponsor trial of favipiravir as preventative measure against Covid-19. (Credit: Visuals3D from Pixabay)